Saturday, August 8, 2026

House subcommittee reviews bills to address illicit drug threats and pill press regulation

Chairman Morgan Griffith delivered an opening statement at a House subcommittee markup reviewing three bills aimed at curbing illicit drug
X / Twitter
LinkedIn
Print

Congressman Morgan Griffith, Chairman of the Subcommittee on Health, delivered an opening statement on July 15 at a markup session considering three bills aimed at combating the illicit drug crisis. The session focused specifically on legislative measures targeting the growing threat posed by pill presses.

Griffith said, “Today’s markup will focus on a few bills that work to combat the illicit drug crisis facing our communities, specifically targeting the growing threat posed by pill presses.” He outlined that these bills would create a regulatory framework allowing the Drug Enforcement Administration (DEA) to oversee a closed system of distribution for pill presses and their critical parts in a manner similar to controlled substances.

He said this approach would ensure legitimate users can access pill presses for intended purposes while giving DEA tools to monitor suspicious orders and prevent diversion for illegal production of counterfeit pills. Among the proposed legislation is H.R. 5880, the Fight Illicit Pill Presses Act led by Representative Hageman from Wyoming. Griffith said this bill “would establish requirements for serial numbers, record keeping, and transaction reporting for pill presses and their critical parts.” Another measure discussed was H.R. 7184, the Preventing Rogue Equipment for Synthetic Substances (PRESS) Act led by Representative McDowell from North Carolina. Griffith said it “would criminalize the importation of pill press equipment with the intent to illicitly produce a controlled substance.” The third bill addressed was H.R. 8005, Stop Pills that Kill Act led by Representative Evans from Colorado; Griffith stated it “would apply enhanced criminal penalties to those who engage in the illicit manufacture of fentanyl, fentanyl analogs, or fentanyl related substances,” and direct DEA efforts against counterfeit pills containing synthetic drugs.

The House Energy and Commerce Committee focuses on legislation concerning energy policy, health care issues including pharmaceutical pricing reforms, environmental protection initiatives such as energy innovation efforts, telecommunications matters like broadband deployment, consumer protections and more, according to the official website. The committee stands as one of the oldest standing committees in Congress with origins tracing back to its formation as Committee on Commerce and Manufactures in 1795.

Griffith concluded his remarks stating: “I look forward to continuing to work on these policies and bringing them to the full Committee.”

Filed Under

Share This Story

X / Twitter
LinkedIn
Email
Print

Advertisement

300 × 250

Related

Daily Dispatch

The morning briefing on federal government — delivered to your inbox before 7 AM.

Advertisement

300 × 120

More from Defense

HUD, Census Report June 2026 New Home Sales Data

The Department of Housing and Urban Development and the U.S. Census Bureau released new residential sales data for June on July 24. The figures provide the most recent snapshot of...

VA Launches Trial of Ozempic Drug for Veteran Alcohol Use Disorder

The Department of Veterans Affairs launched a clinical trial of semaglutide as a potential treatment for alcohol use disorder in veterans on July 30. The condition affects an estimated 400,000...

EPA Proposes to Ease New Hampshire Ozone Compliance Burden

The Environmental Protection Agency proposed to withdraw New Hampshire from the Ozone Transport Region and separately ease the state’s vehicle inspection and maintenance program mandate on Aug. 6. The actions...